Danaparoid: Difference between revisions
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 24: | Line 24: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
'''Danaparoid sodium''' (Orgaran®) is an [[anticoagulant]] that works by inhibiting activated [[factor X]] (factor Xa). | '''Danaparoid sodium''' (Orgaran®) is an [[anticoagulant]] that works by inhibiting activated [[factor X]] (factor Xa). | ||
| Line 42: | Line 42: | ||
==Administration== | ==Administration== | ||
[[Parenteral|IV]] | * [[Parenteral|IV]] | ||
* SC | |||
==Side | ==Side Effects== | ||
*Bleeding problems | *Bleeding problems | ||
*[[Thrombocytopenia|Low platelets]], due to a low level of structural similarity between danaparoid and [[heparin]] | *[[Thrombocytopenia|Low platelets]], due to a low level of structural similarity between danaparoid and [[heparin]] | ||
*[[Asthma]] exacerbations, due to allergies to [[sulphite]]s contained within the medicine | *[[Asthma]] exacerbations, due to allergies to [[sulphite]]s contained within the medicine | ||
==External Links== | |||
* {{MeshName|danaparoid}} | |||
==References== | ==References== | ||
{{reflist|2}} | |||
{{Antithrombotics}} | {{Antithrombotics}} | ||
[[Category:Drug]] | |||
[[Category: | [[Category:Cardiovascular Drugs]] | ||
[[Category:Anticoagulants]] | [[Category:Anticoagulants]] | ||
Latest revision as of 00:52, 26 July 2014
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
|
WikiDoc Resources for Danaparoid |
|
Articles |
|---|
|
Most recent articles on Danaparoid |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Danaparoid at Clinical Trials.gov Clinical Trials on Danaparoid at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Danaparoid
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Danaparoid Discussion groups on Danaparoid Patient Handouts on Danaparoid Directions to Hospitals Treating Danaparoid Risk calculators and risk factors for Danaparoid
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Danaparoid |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Danaparoid sodium (Orgaran®) is an anticoagulant that works by inhibiting activated factor X (factor Xa).
Danaparoid is considered a "low molecular weight heparin" by some sources, but is chemically distinct from heparin and thus has little cross-reactivity in heparin-intolerant patients.
Uses
It is used to prevent deep venous clots, particularly in situations with a high risk of clot formation, such as after hip surgery.
It is also used as a heparinoid substitute in heparin-induced thrombocytopenia which may otherwise cause paradoxical thrombosis.
Discontinuation
On August 14, 2002, this drug was withdrawn by Organon International.[1]
Administration
- IV
- SC
Side Effects
- Bleeding problems
- Low platelets, due to a low level of structural similarity between danaparoid and heparin
- Asthma exacerbations, due to allergies to sulphites contained within the medicine
External Links
- danaparoid at the US National Library of Medicine Medical Subject Headings (MeSH)
References
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Infobox drug articles without a structure image
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drug
- Cardiovascular Drugs
- Anticoagulants